Insecticides (India) Ltd Q4 FY26 Results

Revenue from operations for Q4 FY26 rose 19% YoY to ₹426 crore.
Profit After Tax for Q4 FY26 declined 16% YoY to ₹12 crore.

Reader Takeaway: Top-line growth driven by premium products, but margins face pressure from external headwinds.

What just happened

Insecticides (India) Ltd announced its financial results for the quarter and year ended March 31, 2026. The company reported a robust 19% year-on-year increase in revenue from operations for the fourth quarter, reaching ₹426 crore compared to ₹359 crore in the same period last year. For the full fiscal year FY26, revenue grew 7% to ₹2,140 crore from ₹2,000 crore in FY25.

However, profitability saw a decline. Profit After Tax (PAT) for Q4 FY26 decreased by 16% to ₹12 crore, down from ₹14 crore in Q4 FY25. For the full fiscal year, PAT saw a marginal dip of 2% to ₹139 crore from ₹142 crore in FY25.

Margins also contracted. The Gross Profit Margin fell to 30.2% in Q4 FY26 from 36.6% in Q4 FY25, and the EBITDA margin contracted to 6.0% from 7.9% year-on-year. Full-year EBITDA margin was 10.6% compared to 11.1% in FY25.

Why this matters

The results highlight a mixed performance for Insecticides (India) Ltd. While the company demonstrates strong revenue growth, indicating healthy demand and successful product launches, the decline in profitability and margins raises concerns. Investors will be watching to see if the company can improve its cost management and pricing strategies to translate topline growth into bottom-line expansion.

The backstory

The company's management, led by MD Mr. Rajesh Kumar Aggarwal, attributed the subdued profitability and margin pressures to a challenging operating environment. Factors such as erratic rainfall patterns, restricted field activities, and global supply chain disruptions have impacted operations.

What changes now

Insecticides (India) Ltd continues its focus on product pipeline expansion, premiumization, and strategic collaborations. The company launched five new products in FY26. This strategy aims to drive future growth and market penetration, particularly in the premium product segment, which saw 24% growth in Q4 FY26. Investors will be looking for sustained premiumization and operational efficiency improvements.

Risks to watch

The primary risks revolve around margin compression due to rising input costs or pricing pressures. The company's dependence on agricultural output also makes it susceptible to weather patterns and regulatory changes. Navigating the challenging operating environment and mitigating the impact of external headwinds will be crucial.

Peer comparison

Insecticides (India) Ltd operates in the agrochemical sector, competing with other Indian and multinational players. Companies like UPL, Rallis India, and Bayer CropScience are key players. While specific peer results for Q4 FY26 are not provided in the filing, the broader agrochemical industry often faces similar challenges related to monsoon dependency, input costs, and regulatory compliance.

Context metrics (time-bound)

• Q4 FY26 Revenue: ₹426 crore (up 19% YoY)
• Q4 FY26 PAT: ₹12 crore (down 16% YoY)
• FY26 Revenue: ₹2,140 crore (up 7% YoY)
• FY26 PAT: ₹139 crore (down 2% YoY)
• Premium Products Growth (Q4 FY26): 24%

What to track next

Investors should monitor the company's ability to recover its profit margins in the upcoming quarters. Continued growth in the premium product segment and the success of new product launches will be key indicators. Additionally, management's strategies to mitigate the impact of adverse weather conditions and input cost fluctuations will be important to follow.